Compare EML & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EML | TKNO |
|---|---|---|
| Founded | 1858 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.9M | 138.1M |
| IPO Year | 1995 | 2021 |
| Metric | EML | TKNO |
|---|---|---|
| Price | $20.40 | $3.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.5K | ★ 75.9K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.98% | N/A |
| EPS Growth | ★ 185.40 | 43.86 |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $248,970,345.00 | $40,520,000.00 |
| Revenue This Year | $19.05 | $8.27 |
| Revenue Next Year | N/A | $13.13 |
| P/E Ratio | $183.27 | ★ N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $17.61 | $1.91 |
| 52 Week High | $26.76 | $6.80 |
| Indicator | EML | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 38.80 | 53.69 |
| Support Level | $18.97 | $2.55 |
| Resistance Level | $20.53 | $4.37 |
| Average True Range (ATR) | 0.73 | 0.33 |
| MACD | -0.30 | -0.02 |
| Stochastic Oscillator | 21.14 | 31.57 |
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.